Elsevier

The Annals of Thoracic Surgery

Volume 98, Issue 5, November 2014, Pages 1742-1747
The Annals of Thoracic Surgery

Original article
General thoracic
Risk Factors Associated With Lung Retransplantation: Evaluation of a Nationwide Registry Over a Quarter Century

Presented at the Fiftieth Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 25–29, 2014.
https://doi.org/10.1016/j.athoracsur.2014.06.033Get rights and content

Background

The relative paucity of donors heightens the debate and scrutiny surrounding retransplantation. To date, risk factors associated with retransplantation are poorly characterized in the literature. We sought to identify those risk factors that may independently serve to predict lung retransplantation.

Methods

We performed a retrospective evaluation of the United Network for Organ Sharing data over 25 years from 1987 to 2012. Competing risk analysis was used to evaluate the cohort for cumulative incidence of retransplantation. Recipient-related, donor-related, and transplant-related characteristics were assessed using Cox regression to identify risk factors associated with lung retransplantation.

Results

We identified 23,180 adult lung transplant recipients, of which 791 (3.4%) had also undergone retransplantation. Factors associated with lung retransplantation at 1 year included recipient age (hazard ratio [HR], 0.97; p = 0.005), admission to the intensive care unit (HR, 2.89; p = 0.002), donor age (HR, 1.02; p = 0.004), and bilateral lung transplantation (HR, 0.41; p < 0.001). Moreover, predictors of 5-year risk of retransplantation included recipient age (HR, 0.95; p < 0.001), intensive care unit hospitalization (HR, 1.87; p = 0.005), and bilateral lung transplant (HR, 0.46; p < 0.001), as well as recipient body mass index of 25 to 29 kg/m2 (HR, 1.29; p = 0.04) and a diagnosis of chronic obstructive pulmonary disease (HR, 0.68; p = 0.008).

Conclusions

We identified factors associated with retransplantation that may afford a better prediction of graft failure and need for retransplantation. These may further serve to better guide donor selection and assist in the development and validation of a risk-scoring model to further guide preoperative counseling.

Section snippets

Material and Methods

We performed a retrospective evaluation of data obtained from Scientific Registry of Transplant Recipients (SRTR) Standard Transplant Analysis and Research files provided by the United Network for Organ Sharing (UNOS). This comprised a data set of a prospectively collected open cohort of consecutive United States adult lung transplant recipients who had undergone lung transplantation between 1987 and 2012. The University of Pittsburgh Medical Center institutional review board (IRB) approved

Results

We identified 23,180 adults who received lung allografts, 791 (3.4%) of whom subsequently underwent lung retransplantation. After 1 year and 5 years of primary transplant, 210 (0.9%) and 582 (2.5%) patients underwent retransplantation. A total of 4,261 patients (18.4%) and 9,386 patients (40.5%) in the cohort were dead at 1 year and 5 years after the initial transplantation.

Table 1 compares recipient-related, donor-related, and transplant-related characteristics. Patients who underwent

Comment

An evaluation of the risk factors for retransplantation may better allow a prediction of which recipients may require repeat allocation of this scarce commodity. This should, in turn, allow for a means to better prepare for the eventuality. Numerous single-center accounts within the literature have identified chronic graft failure as the most justifiable indication for lung retransplantation. These suggest, in addition, that recipients undergoing retransplantation for BOS have an almost

References (23)

Cited by (0)

View full text